These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 8632906

  • 41. Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
    Seo S, Nakamoto T, Takeshita M, Lu J, Sato T, Suzuki T, Kamikubo Y, Ichikawa M, Noda M, Ogawa S, Honda H, Oda H, Kurokawa M.
    Cancer Sci; 2011 Dec; 102(12):2109-17. PubMed ID: 21848808
    [Abstract] [Full Text] [Related]

  • 42. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD, Langdon WY.
    Oncogene; 1995 Oct 19; 11(8):1561-7. PubMed ID: 7478580
    [Abstract] [Full Text] [Related]

  • 43. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T, Aleman LM, Smith JM, Adler CE, Mayer BJ.
    Oncogene; 2001 Jul 05; 20(30):4058-69. PubMed ID: 11494134
    [Abstract] [Full Text] [Related]

  • 44. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin.
    Oda A, Miyakawa Y, Druker BJ, Ishida A, Ozaki K, Ohashi H, Wakui M, Handa M, Watanabe K, Okamoto S, Ikeda Y.
    Blood; 1996 Dec 01; 88(11):4304-13. PubMed ID: 8943867
    [Abstract] [Full Text] [Related]

  • 45. Alpha 4 beta 1 integrin-mediated tyrosine phosphorylation in human T cells: characterization of Crk- and Fyn-associated substrates (pp105, pp115, and human enhancer of filamentation-1) and integrin-dependent activation of p59fyn1.
    Hunter AJ, Shimizu Y.
    J Immunol; 1997 Nov 15; 159(10):4806-14. PubMed ID: 9366405
    [Abstract] [Full Text] [Related]

  • 46. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
    Ren R, Ye ZS, Baltimore D.
    Genes Dev; 1994 Apr 01; 8(7):783-95. PubMed ID: 7926767
    [Abstract] [Full Text] [Related]

  • 47. Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy.
    Yeh CH, Abdool A, Bruey JM.
    Cancer Biomark; 2010 Apr 01; 7(6):295-303. PubMed ID: 21694468
    [Abstract] [Full Text] [Related]

  • 48. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J.
    Cell; 1993 Oct 08; 75(1):175-85. PubMed ID: 8402896
    [Abstract] [Full Text] [Related]

  • 49. Networks of interaction of p120cbl and p130cas with Crk and Grb2 adaptor proteins.
    Khwaja A, Hallberg B, Warne PH, Downward J.
    Oncogene; 1996 Jun 20; 12(12):2491-8. PubMed ID: 8700507
    [Abstract] [Full Text] [Related]

  • 50. Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation.
    Shi CS, Tuscano J, Kehrl JH.
    Blood; 2000 Feb 01; 95(3):776-82. PubMed ID: 10648385
    [Abstract] [Full Text] [Related]

  • 51. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
    Nieborowska-Skorska M, Slupianek A, Skorski T.
    Oncogene; 2000 Aug 24; 19(36):4117-24. PubMed ID: 10962572
    [Abstract] [Full Text] [Related]

  • 52. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T, Akagi T, Chalmers A, Maeda M, Terada T, Georgescu MM, Hanafusa H.
    Genes Cells; 2001 May 24; 6(5):431-40. PubMed ID: 11380621
    [Abstract] [Full Text] [Related]

  • 53. A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors.
    Seo JH, Wood LJ, Agarwal A, O'Hare T, Elsea CR, Griswold IJ, Deininger MW, Imamoto A, Druker BJ.
    Cancer Res; 2010 Sep 15; 70(18):7325-35. PubMed ID: 20807813
    [Abstract] [Full Text] [Related]

  • 54. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R.
    J Clin Invest; 1993 Oct 15; 92(4):1925-39. PubMed ID: 8408645
    [Abstract] [Full Text] [Related]

  • 55. CRKL binding to BCR-ABL and BCR-ABL transformation.
    Kolibaba KS, Bhat A, Heaney C, Oda T, Druker BJ.
    Leuk Lymphoma; 1999 Mar 15; 33(1-2):119-26. PubMed ID: 10194128
    [Abstract] [Full Text] [Related]

  • 56. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H.
    Clin Cancer Res; 1998 Jul 15; 4(7):1661-72. PubMed ID: 9676840
    [Abstract] [Full Text] [Related]

  • 57. Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2.
    Patel H, Marley SB, Gordon MY.
    Genes Chromosomes Cancer; 2006 Dec 15; 45(12):1121-9. PubMed ID: 16955467
    [Abstract] [Full Text] [Related]

  • 58. Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    van Denderen J, van der Plas D, Meeuwsen T, Zegers N, Boersma W, Grosveld G, van Ewijk W.
    Blood; 1990 Jul 01; 76(1):136-41. PubMed ID: 2194587
    [Abstract] [Full Text] [Related]

  • 59. Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.
    Ren SY, Bolton E, Mohi MG, Morrione A, Neel BG, Skorski T.
    Mol Cell Biol; 2005 Sep 01; 25(18):8001-8. PubMed ID: 16135792
    [Abstract] [Full Text] [Related]

  • 60. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia.
    Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ.
    J Biol Chem; 1994 Sep 16; 269(37):22925-8. PubMed ID: 8083188
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.